Related Experiment Video
Updated: May 9, 2026

08:47
Endoscopic Cholesteatoma Surgery
Published on: January 19, 2022
Management of mycetomas in France
S Mattioni1, M Develoux, S Brun
1Service de maladies infectieuses et tropicales, hôpital Avicenne, AP-HP, 125, rue de Stalingrad, 93000 Bobigny, France. sarah.mattioni@tnn.aphp.fr
Medecine Et Maladies Infectieuses
|August 7, 2013
Summary
Mycetoma, a chronic tropical infection, is difficult to treat, especially eumycetoma. This study highlights delayed diagnosis and poor antifungal treatment outcomes in France, emphasizing surgical intervention for eumycetoma.
Area of Science:
- Medical Mycology
- Tropical Infectious Diseases
- Dermatology
Background:
- Mycetomas are chronic subcutaneous infections caused by fungi (eumycetes) or bacteria (actinomycetes), presenting as multi-fistulized pseudotumors.
- Eumycetoma is particularly challenging to treat and represents a significant global health issue in tropical and subtropical regions.
- While rare in France, mycetoma cases in developed countries may benefit from broader treatment options.
Purpose of the Study:
- To present the clinical presentation and management of mycetoma cases diagnosed in a developed country (France).
- To analyze treatment outcomes, particularly the efficacy of antifungal therapies in a non-endemic setting.
Main Methods:
- Retrospective study of mycetoma cases from 1995 to 2011 at Bobigny Avicenne teaching hospital.
- Analysis of clinical presentation, etiology, bone involvement, and treatment management.
Main Results:
- Six male patients (median age 31) were studied, with five from Sub-Saharan Africa and one from Sri Lanka.
- Five eumycetomas and one actinomycetoma were diagnosed, with bone involvement in five cases; one atypical intra-osseous mycetoma was noted.
- Three patients were cured (two surgically, one medically for actinomycetoma); antifungal therapy failed in all four eumycetoma cases.
Conclusions:
- Mycetoma diagnosis and management are often delayed in non-endemic areas like France due to its rarity.
- Newer broad-spectrum antifungals (triazoles, caspofungin) showed no efficacy in treating eumycetoma in this cohort.
- Surgical management appears more effective for eumycetoma, while medical treatment was successful for the single actinomycetoma case.